Status:
COMPLETED
Study on Infectious Mononucleosis in Munich
Lead Sponsor:
Technical University of Munich
Collaborating Sponsors:
Helmholtz Zentrum München
German Cancer Research Center
Conditions:
Infectious Mononucleosis
Epstein-Barr Virus Infections
Eligibility:
All Genders
Up to 39 years
Brief Summary
This observational clinical study aims at the identification of novel biomarkers and causative factors of complicated and/or protracted Epstein-Barr virus-associated infectious mononucleosis (IM). Cl...
Detailed Description
EBV-associated diseases are a severe and global health problem, and novel tools and targets for a better pathogenetic understanding, diagnosis, treatment, and prevention are clearly needed. Here we pr...
Eligibility Criteria
Inclusion
- IM onset within the last four weeks
- with at least one of four typical clinical findings (tonsillopharyngitis, fever, lymphadenopathy, fatigue) - virological findings indicating primary EBV infection (EBV-specific antibodies, EBV DNA).
Exclusion
- Pregnancy
- transfusion
- and/or transplantation during the last year
- and/or no informed consent.
Key Trial Info
Start Date :
March 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06002802
Start Date
March 1 2016
End Date
August 31 2020
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MRI Chonic Fatigue Center for Young People (MCFC), Children's Hospital, Technical University of Munich & Munich Municipal Hospital
Munich, Bavaria, Germany, 80804